Search

everythinglearnresearchcommunity

for

Search:↓

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

PRP therapy increases hair density for androgenetic alopecia.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Nanoparticles improve minoxidil skin permeation, but more research needed for effective hair growth.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Hair loss requires customized treatments based on its various causes and types.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

People with HIV and low T cell counts have more hair and scalp problems.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Improved dermabrasion techniques in 1987 led to better treatment results for skin issues like acne scars.

Effervescent formulations may improve minoxidil delivery, increasing effectiveness and reducing applications needed.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.